Current use of low molecular weight heparins.
Donayre
C E
CE
Department of Surgery, University of California, Los Angeles, USA.
D000925:Anticoagulants / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010974:Platelet Aggregation; D016032:Randomized Controlled Trials as Topic; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy; D013927:Thrombosis / Q000517:prevention & control; D014656:Vascular Surgical Procedures
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin